247 related articles for article (PubMed ID: 29253627)
21. Neutrophil Gelatinase-Associated Lipocalin and Retinol-Binding Protein-4 as Biomarkers for Diabetic Kidney Disease.
Abbasi F; Moosaie F; Khaloo P; Dehghani Firouzabadi F; Fatemi Abhari SM; Atainia B; Ardeshir M; Nakhjavani M; Esteghamati A
Kidney Blood Press Res; 2020; 45(2):222-232. PubMed ID: 32008005
[TBL] [Abstract][Full Text] [Related]
22. Nonalbuminuric proteinuria as a biomarker for tubular damage in early development of nephropathy with type 2 diabetic patients.
Kim SS; Song SH; Kim IJ; Kim WJ; Jeon YK; Kim BH; Kwak IS; Lee EK; Kim YK
Diabetes Metab Res Rev; 2014 Nov; 30(8):736-41. PubMed ID: 24687388
[TBL] [Abstract][Full Text] [Related]
23. Clinical markers and some trace elements in patients with type-2 diabetic nephropathy : Impact of insulin resistance.
Al-Fartosy AJM; Awad NA; Alsalimi SA
J Med Invest; 2021; 68(1.2):76-84. PubMed ID: 33994484
[TBL] [Abstract][Full Text] [Related]
24. Urinary monocyte chemoattractant protein-1 and vitamin D-binding protein as biomarkers for early detection of diabetic nephropathy in type 2 diabetes mellitus.
Shoukry A; Bdeer Sel-A; El-Sokkary RH
Mol Cell Biochem; 2015 Oct; 408(1-2):25-35. PubMed ID: 26104579
[TBL] [Abstract][Full Text] [Related]
25. Assessment of two novel renal tubular proteins in type 2 diabetic patients with nephropathy.
Abdel Ghafar MT; Shalaby KH; Okda HI; Abo El Gheit RE; Soliman NA; Keshk WA
J Investig Med; 2020 Mar; 68(3):748-755. PubMed ID: 31722957
[TBL] [Abstract][Full Text] [Related]
26. Diagnostic efficacy of serum and urinary netrin-1 in the early detection of diabetic nephropathy.
Elkholy RA; Younis RL; Allam AA; Hagag RY; Abdel Ghafar MT
J Investig Med; 2021 Aug; 69(6):1189-1195. PubMed ID: 33863755
[TBL] [Abstract][Full Text] [Related]
27. ApoM/HDL-C and apoM/apoA-I ratios are indicators of diabetic nephropathy in healthy controls and type 2 diabetes mellitus.
Zhang P; Gao J; Pu C; Feng G; Wang L; Huang L; Zhang Y
Clin Chim Acta; 2017 Mar; 466():31-37. PubMed ID: 28073663
[TBL] [Abstract][Full Text] [Related]
28. Decreased serum myonectin concentrations in diabetic nephropathy patients.
Zhang J; Hu W; Lin P; Wang R
Clin Exp Med; 2020 Nov; 20(4):601-607. PubMed ID: 32852729
[TBL] [Abstract][Full Text] [Related]
29. Assessment of Serum and Urine Neurophil Gelatinase- Associated Lipocalin (s-NGAL and u-NGAL) Level as a Predictive Factor of Disease Progression in Diabetic Nephropathy in Type 2 DM.
Najafi L; Keshtkar Rajabi S; Pirsaheb S; Keyvani H; Khajavi A; Shati M; Hadavand F; Amouzegar A
Iran J Kidney Dis; 2021 Jul; 15(4):270-278. PubMed ID: 34278998
[TBL] [Abstract][Full Text] [Related]
30. Serum chromogranin A correlated with albuminuria in diabetic patients and is associated with early diabetic nephropathy.
Yu H; Wang H; Su X; Cao A; Yao X; Wang Y; Zhu B; Wang H; Fang J
BMC Nephrol; 2022 Jan; 23(1):41. PubMed ID: 35062888
[TBL] [Abstract][Full Text] [Related]
31. Overexpression of Serum Micro-RNA 152-3p in Type 2 Diabetes Mellitus with a Significant Elevation in Progressive Nephropathy.
Nasser M; Ibrahim KMF; Elnabawi WM; Ahmed TM
Egypt J Immunol; 2020 Jun; 27(2):81-92. PubMed ID: 33548980
[TBL] [Abstract][Full Text] [Related]
32. Detection of an earlier tubulopathy in diabetic nephropathy among children with normoalbuminuria.
Hafez MH; El-Mougy FA; Makar SH; Abd El Shaheed S
Iran J Kidney Dis; 2015 Mar; 9(2):126-31. PubMed ID: 25851291
[TBL] [Abstract][Full Text] [Related]
33. Novel urinary biomarkers in pre-diabetic nephropathy.
Garg V; Kumar M; Mahapatra HS; Chitkara A; Gadpayle AK; Sekhar V
Clin Exp Nephrol; 2015 Oct; 19(5):895-900. PubMed ID: 25634253
[TBL] [Abstract][Full Text] [Related]
34. Serum Adipocyte Fatty Acid-Binding Protein 4 Levels Are Independently Associated with Radioisotope Glomerular Filtration Rate in Type 2 Diabetic Patients with Early Diabetic Nephropathy.
Ni X; Gu Y; Yu H; Wang S; Chen Y; Wang X; Yuan X; Jia W
Biomed Res Int; 2018; 2018():4578140. PubMed ID: 29992142
[TBL] [Abstract][Full Text] [Related]
35. Endocan and albuminuria in type 2 diabetes mellitus.
Cikrikcioglu MA; Erturk Z; Kilic E; Celik K; Ekinci I; Yasin Cetin AI; Ozkan T; Cetin G; Dae SA; Kazancioglu R; Erkoc R
Ren Fail; 2016 Nov; 38(10):1647-1653. PubMed ID: 27756187
[TBL] [Abstract][Full Text] [Related]
36. Serum Irisin and Diabetic Nephropathy in Patients with Diabetes Mellitus.
Kawada T
Horm Metab Res; 2021 Dec; 53(12):825. PubMed ID: 34891213
[TBL] [Abstract][Full Text] [Related]
37. Urinary heme oxygenase-1 as a potential biomarker for early diabetic nephropathy.
Li Z; Xu Y; Liu X; Nie Y; Zhao Z
Nephrology (Carlton); 2017 Jan; 22(1):58-64. PubMed ID: 26733347
[TBL] [Abstract][Full Text] [Related]
38. Urinary tubular biomarkers as predictors of kidney function decline, cardiovascular events and mortality in microalbuminuric type 2 diabetic patients.
Rotbain Curovic V; Hansen TW; Eickhoff MK; von Scholten BJ; Reinhard H; Jacobsen PK; Persson F; Parving HH; Rossing P
Acta Diabetol; 2018 Nov; 55(11):1143-1150. PubMed ID: 30105469
[TBL] [Abstract][Full Text] [Related]
39. NGAL and cystatin C: two possible early markers of diabetic nephropathy in young patients with type 1 diabetes mellitus: one year follow up.
Papadopoulou-Marketou N; Skevaki C; Kosteria I; Peppa M; Chrousos GP; Papassotiriou I; Kanaka-Gantenbein C
Hormones (Athens); 2015; 14(2):232-40. PubMed ID: 25402375
[TBL] [Abstract][Full Text] [Related]
40. "Normoalbuminuric" diabetic nephropathy: tubular damage and NGAL.
Lacquaniti A; Donato V; Pintaudi B; Di Vieste G; Chirico V; Buemi A; Di Benedetto A; Arena A; Buemi M
Acta Diabetol; 2013 Dec; 50(6):935-42. PubMed ID: 23754672
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
